Peddock Capital Advisors’s Eli Lilly LLY Stock Holding History

Peddock Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.93M	Buy	5,123 +16	+0.3%	+$18.9K	1.15%	22
2026 Q2	$6.13M	Buy	5,107 +6	+0.1%	+$6.13K	1.22%	20
2026 Q1	$4.69M	Sell	5,101 -23	-0.4%	-$23.3K	1.03%	21
2025 Q4	$5.51M	Hold	5,124	–	–	1.15%	20
2025 Q3	$3.91M	Hold	5,124	–	–	0.84%	29
2025 Q2	$3.99M	Hold	5,124	–	–	0.92%	24
2025 Q1	$4.23M	Buy	5,124 +23	+0.5%	+$19.1K	1.07%	21
2024 Q4	$3.94M	Hold	5,101	–	–	0.94%	23
2024 Q3	$4.52M	Hold	5,101	–	–	1.09%	19
2024 Q2	$4.62M	Sell	5,101 -6	-0.1%	-$4.8K	1.19%	19
2024 Q1	$3.97M	Hold	5,107	–	–	1.04%	21
2023 Q4	$2.98M	Hold	5,107	–	–	0.91%	22
2023 Q3	$2.74M	Buy	5,107 +10	+0.2%	+$5.15K	0.91%	22
2023 Q2	$2.39M	Hold	5,097	–	–	0.79%	30
2023 Q1	$1.75M	Hold	5,097	–	–	0.61%	43
2022 Q4	$1.86M	Sell	5,097 -19	-0.4%	-$6.74K	0.72%	40
2022 Q3	$1.65M	Hold	5,116	–	–	0.68%	43
2022 Q2	$1.66M	Hold	5,116	–	–	0.65%	46
2022 Q1	$1.46M	Hold	5,116	–	–	0.47%	58
2021 Q4	$1.41M	Hold	5,116	–	–	0.47%	58
2021 Q3	$1.18M	Buy	5,116 +5	+0.1%	+$1.23K	0.42%	65
2021 Q2	$1.24M	Sell	5,111 -144	-3%	-$28.9K	0.44%	64
2021 Q1	$982K	Hold	5,255	–	–	0.38%	69
2020 Q4	$887K	Sell	5,255 -6	-0.1%	-$896	0.46%	56
2020 Q3	$779K	Sell	5,261 -96	-2%	-$14.9K	0.48%	55
2020 Q2	$880K	Hold	5,357	–	–	0.56%	43
2020 Q1	$743K	Hold	5,357	–	–	0.56%	46
2019 Q4	$704K	Hold	5,357	–	–	0.36%	60
2019 Q3	$599K	Hold	5,357	–	–	0.33%	64
2019 Q2	$594K	Sell	5,357 -125	-2%	-$14.7K	0.32%	66
2019 Q1	$711K	Sell	5,482 -34	-0.6%	-$4.13K	0.39%	55
2018 Q4	$638K	Hold	5,516	–	–	0.38%	57
2018 Q3	$592K	Hold	5,516	–	–	0.29%	69
2018 Q2	$471K	Hold	5,516	–	–	0.24%	76
2018 Q1	$427K	Hold	5,516	–	–	0.23%	79
2017 Q4	$466K	Hold	5,516	–	–	0.23%	78
2017 Q3	$472K	Hold	5,516	–	–	0.24%	75
2017 Q2	$454K	Hold	5,516	–	–	0.24%	73
2017 Q1	$464K	Hold	5,516	–	–	0.27%	66
2016 Q4	$406K	Buy	5,516 +432	+8%	+$32.2K	0.24%	69
2016 Q3	$408K	Hold	5,084	–	–	0.25%	65
2016 Q2	$400K	Hold	5,084	–	–	0.26%	60
2016 Q1	$366K	Hold	5,084	–	–	0.28%	60
2015 Q4	$428K	Buy	5,084 +450	+10%	+$37.3K	0.33%	61
2015 Q3	$388K	Buy	4,634 +34	+0.7%	+$2.87K	0.35%	65
2015 Q2	$384K	Hold	4,600	–	–	0.31%	76
2015 Q1	$334K	Hold	4,600	–	–	0.28%	82
2014 Q4	$317K	Hold	4,600	–	–	0.26%	84
2014 Q3	$298K	Hold	4,600	–	–	0.24%	75
2014 Q2	$286K	Hold	4,600	–	–	0.22%	76
2014 Q1	$271K	Hold	4,600	–	–	0.21%	76
2013 Q4	$235K	Buy	+4,600	New	+$230K	0.18%	80

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Peddock Capital Advisors's LLY Position: Q3 2026 in Review

Peddock Capital Advisors increased its Eli Lilly (LLY) stake by 0.31% in Q3 2026, buying an estimated $18.9K and bringing the position to 5,123 shares worth $5.93M. The position accounts for 1.15% of the portfolio, ranked #22.

Peddock Capital Advisors first reported a position in LLY in Q4 2013 and has held it in 52 quarters since. The position peaked at $6.13M in Q2 2026. 1,514 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Peddock Capital Advisors held 5,123 shares of Eli Lilly worth $5.93M as of Q3 2026.
Peddock Capital Advisors bought 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
Eli Lilly made up 1.15% of Peddock Capital Advisors's portfolio in Q3 2026, its #22 holding.
Peddock Capital Advisors first reported a position in Eli Lilly in Q4 2013 and has held it in 52 quarters since.
Peddock Capital Advisors's Eli Lilly position peaked at $6.13M in Q2 2026.
1,514 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Peddock Capital Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.